Onconova Therapeutics Inc

NASDAQ:ONTX 4:00:00 PM EDT

0.72

0.00 (0.00%)

4:49:27 PM EDT: $0.73 +0.01 (+1.39%)

Products

Onconova Therapeutics Announces FDA Permission For Study To Proceed Under Its Investigational New Drug Application For Multi-Kinase Cdk4/6 Inhibitor On 123300

Published: 12/21/2020 16:26 GMT

Onconova Therapeutics Inc (ONTX) - Onconova Therapeutics Announces FDA Permission for Study to Proceed Under Its Investigational New Drug Application for Multi-kinase Cdk4/6 Inhibitor on 123300.
Onconova Therapeutics Inc - First Patient Will Be Enrolled During First Half of 2021 for Phase 1 Trial With on 123300.